References
- John ATS, Stuart KA, Crawford DHG. Testing for HFE-related
haemochromatosis. Aust Prescr 2011; 34:73-6. doi:
10.18773/austprescr.2011.046
- Nicholas C. P. Cross; Genetic and Epigenetic Complexity in
Myeloproliferative Neoplasms. Hematology Am Soc Hematol Educ
Program 2011; 2011 (1): 208–214. doi:
10.1182/asheducation-2011.1.208. PMID: 22160036.
- Cuthbert D, Stein BL. Polycythemia Vera-Associated Complications:
Pathogenesis, Clinical Manifestations, And Effects On Outcomes. J
Blood Med. 2019 Oct 18; 10:359-371. doi:10.2147/JBM.S189922
- Daniel A. Arber, Attilio Orazi, Robert Hasserjian, Jürgen Thiele,
Michael J. Borowitz, Michelle M. Le Beau, Clara D. Bloomfield, Mario
Cazzola, James W. Vardiman; The 2016 revision to the World Health
Organization classification of myeloid neoplasms and acute
leukemia. Blood 2016; 127 (20): 2391–2405. doi:
10.1182/blood-2016-03-643544
- Prevalence of HFE genotypes, C282Y and H63D, in patients with
hematologic disorders. Hannuksela J, Savolainen ER, Koistinen P,
Parkkila S. Haematologica. 2002 Feb;87(2):131-5. doi: 10.3324/%25x
- Franchini M, de Matteis G, Federici F, Solero P, Veneri D. Analysis of
hemochromatosis gene mutations in 52 consecutive patients with
polycythemia vera. Hematology. 2004 Oct-Dec;9(5-6):413-4. doi:
10.1080/10245330400001934. PMID: 15763983.
- Prabhsimranjot Singh, Sudhamshi Toom, Makardhwaj S Shrivastava,
William B. Solomon; A Rare Combination of Genetic Mutations in an
Elderly Female: A Diagnostic Dilemma!. Blood 2016; 128 (22):
5487. doi: 10.1182/blood.V128.22.5487.5487